Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 19-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 20)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
17-May-13 Reuters Investment Profile N/A Navidea Biopharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
17-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - NAVIDEA BIOPHARMACEUTICALS INC (NAVB-A) 11 $25 View Abstract
17-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical Instruments 17 $195.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: FLDM , GNMK , IMSC , MGCD , NAVB , SURG , KOOL -- MEDICAL SUPPLIES & EQUIPMENT 3 $34.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: NAVIDEA BIOPHARM -- NAVB 1 $11.50 View Abstract
12-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: NAVIDEA BIOPHARMACEUTICALS 5 $10 View Abstract
10-May-13 Plunkett Research, Ltd. Jack W Plunkett Navidea Biopharmaceuticals Inc (NAVB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages 48 $99 View Abstract
8-May-13 Zacks Investment Research Inc. N/A NAVIDEA BIOPHAR (NAVB) Zacks Company Snapshot 1 $11.50 View Abstract
6-May-13 Alpha Street Research Hunter Orr Full Coverage Universe - Alpha Street 1-10 Ranking Overview 81 $48 View Abstract
5-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: NAVIDEA BIOPHARMACEUTICALS 5 $10 View Abstract
Next 10

Independent Reports (Showing 1 to 10 of 20)

Release
Date Contributor Author Title Pages Price More Info
17-May-13 Reuters Investment Profile N/A Navidea Biopharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
17-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - NAVIDEA BIOPHARMACEUTICALS INC (NAVB-A) 11 $25 View Abstract
17-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical Instruments 17 $195.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: FLDM , GNMK , IMSC , MGCD , NAVB , SURG , KOOL -- MEDICAL SUPPLIES & EQUIPMENT 3 $34.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: NAVIDEA BIOPHARM -- NAVB 1 $11.50 View Abstract
12-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: NAVIDEA BIOPHARMACEUTICALS 5 $10 View Abstract
10-May-13 Plunkett Research, Ltd. Jack W Plunkett Navidea Biopharmaceuticals Inc (NAVB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages 48 $99 View Abstract
8-May-13 Zacks Investment Research Inc. N/A NAVIDEA BIOPHAR (NAVB) Zacks Company Snapshot 1 $11.50 View Abstract
6-May-13 Alpha Street Research Hunter Orr Full Coverage Universe - Alpha Street 1-10 Ranking Overview 81 $48 View Abstract
5-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: NAVIDEA BIOPHARMACEUTICALS 5 $10 View Abstract
Next 10

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.